Targeted disruption of EphA2 also impaired normal mammary epithelial growth and branching morphogenesis [12], as well as tumor initiation and lung metastasis in the MMTV-Neu transgenic model of mammary adenocarcinoma [18]. The gene discussed is EPHA2; the disease is neoplasm.